Cargando…
Significance of KIT exon 17 mutation depends on mutant level rather than positivity in core-binding factor acute myeloid leukemia
KIT exon 17 mutation is a poor prognostic factor in core-binding factor acute myeloid leukemia. However, the mutation detection method used for risk assessment is not assigned. It is necessary to verify the analytical and clinical performance before applying new methods. Herein, we firstly applied a...
Autores principales: | Jang, W, Yoon, J-H, Park, J, Lee, G D, Kim, J, Kwon, A, Choi, H, Han, K, Nahm, C H, Kim, H-J, Min, W-S, Kim, M, Kim, Y |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742633/ https://www.ncbi.nlm.nih.gov/pubmed/26771813 http://dx.doi.org/10.1038/bcj.2015.116 |
Ejemplares similares
-
Synergistic Targeting of DNA-PK and KIT Signaling Pathways in KIT Mutant Acute Myeloid Leukemia
por: Murray, Heather C., et al.
Publicado: (2023) -
Detection of KIT mutations in core binding factor acute myeloid leukemia
por: Badr, Passant, et al.
Publicado: (2018) -
Cardiac circRNAs arise mainly from constitutive exons rather than alternatively spliced exons
por: Aufiero, Simona, et al.
Publicado: (2018) -
Avapritinib treatment of KIT D816V-mutant atypical chronic myeloid leukemia
por: Sandow, Lyndsey, et al.
Publicado: (2023) -
Fibril polymorphism affects immobilized non-amyloid flanking domains of huntingtin exon1 rather than its polyglutamine core
por: Lin, Hsiang-Kai, et al.
Publicado: (2017)